Affinity Asset Advisors »

BioMarin Pharmaceutical shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 15k 70.29
2023-03-31 $2.4M 25k 97.24
2022-12-31 $8.3M 80k 103.49

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Verona Pharma Sponsored Ads (VRNA)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nuvalent Inc-a (NUVL)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Vera Therapeutics Cl A (VERA)
Nurix Therapeutics (NRIX)

View all positions for Affinity Asset Advisors

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Ameriprise Financial
Norges Bank Investment Management
Elliott Investment Management
Geode Capital Management
Bank of New York Mellon
Northern Trust
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co

View all funds holding BioMarin Pharmaceutical